Related Stories

Seeking Balance: TMA Opposes Feds' Implementation of the No Surprises Act - 04/09/2024

The Texas Medical Association supported the patient protections in the federal No Surprises Act but also knew from the beginning that the law's payment arbitration provisions were flawed and could give insurers an advantage.

RICO Settlements: TMA's Leadership Against Payer Abuses Resulted in Relief, Reform - 04/09/2024

Back in 2001, the Texas Medical Association and the other plaintiffs alleged the nation’s major health plans had conspired to delay and reduce payments to clinicians and hospitals; the resulting lawsuits, brought under the federal Racketeer Influenced and Corrupt Organizations Act (RICO), represented a watershed moment in TMA history.

Exceptional Circumstances: TMA Advocates “Legislative Clarity” Amid State Abortion Bans - 03/05/2024

TMA advocates “legislative clarity” amid state abortion bans.

Physicians’ DEA Registration Now Requires Training on Substance Use Disorder - 01/03/2024

Physicians who must register or renew their registration for a Drug Enforcement Administration license will face a new requirement as of June 27: To register, they will have attest to taking a one-time, eight-hour training on how to treat patients with opioid or other substance use disorders.

Feds Extend Telemedicine Prescribing Flexibilities Through 2024 - 11/10/2023

With permanent telehealth prescribing policies still under consideration, the U.S. Drug Enforcement Administration (DEA) again has extended temporary pandemic-era telehealth flexibilities to allow physicians to virtually prescribe certain controlled medications, now through Dec. 31, 2024.

CDC Grant Funds Drug Overdose Data Collection in Texas - 10/30/2023

A nearly $4 million grant from the Centers for Disease Control and Prevention could give Texas physicians new tools to handle national opioid and mental health crises, which have made it difficult to identify patients at risk for substance use disorders.

Help Promote National Drug Prescription Take Back Day on Oct. 28 - 10/19/2023

Prescription Drug Take Back Day, which allows people to dispose of prescription drugs safely and anonymously, is scheduled for Oct. 26 at locations throughout the state.

TMA Wins Two More Surprise Billing Lawsuits; CMS Suspends Arbitrations - 10/03/2023

Marking a fourth victory for the Texas Medical Association in as many lawsuits, a court on Aug. 24 struck down a large portion of the regulations setting forth a methodology insurers use to calculate the qualifying payment amount, or QPA, used in surprise-billing disputes – part of a series of federal rules TMA has long argued skew the arbitration process in insurers’ favor.

Noncompete Concerns Spark Ongoing TMA Advocacy, Resources - 09/19/2023

The Texas Medical Association continues to receive reports of physician concerns over noncompete agreements, underscoring medicine’s ongoing legislative and regulatory advocacy efforts to strike a balance that works for physician employers and employed physicians alike.

Physicians Warn: New Drug Overdose Threat Contains Veterinary Tranquilizer Xylazine - 09/18/2023

Xylazine, a tranquilizer used in veterinary medicine, is appearing in illicit street drugs with fentanyl, compounding the dangers of the opioid overdose epidemic. Xylazine, also called “tranq” according to the U.S. Drug Enforcement Administration, is used to tranquilize animals. It is not approved for human use and has killed people who have taken the drug.

Physicians Alarmed by Sharp Spike in Accidental Overdose Deaths Fueled by Illegal Drugs - 09/18/2023

A surge in accidental opioid overdose deaths in Texas is showing no signs of slowing down, and Texas physicians warn the rise in illegally produced drugs laced with fentanyl are to blame. They also say increasing the availability of life-saving, overdose-reversing drugs like naloxone, as well as addiction treatment programs, can help.

Physicians Urge Texans to Safely Return Unused Prescription Medication - 09/18/2023

Texas physicians recommend people with unused or expired prescription drugs at home dispose of them safely this weekend, so they are not accidently consumed. The U.S. Drug Enforcement Administration is organizing its biannual prescription drug Take Back Day on Saturday, Oct. 29. Prescription drugs can be returned anonymously at pop up locations across the state.

Opioids: Resources for Prescribing and Addiction Treatment - 07/20/2023

Get access to information about medication-assisted treatment for opioid use disorder. Online resources for prescribing opioids appropriately also are available.

Practice E-Tips on Legal Topics - 07/20/2023

TMA Practice E-Tips on Legal Topics

Fighting Back: Practice Wins Court Battle Over Defamatory Online Reviews - 06/20/2023

One practice’s recent legal battle epitomizes physicians’ worst nightmares when it comes to online reviews. Here’s an extreme but glaring real world example, straight from the documents in a lawsuit that Austin Eye first filed in October 2017 over

Welcome MAT: Physicians Debunk Skepticism of Medication-Assisted Treatment - 06/05/2023

Many physicians have concerns about medication-assisted treatment (MAT) for substance use disorders. But a better understanding of MAT – combined with recent changes in federal law about prescribing these medications and required physician education on the subject – will allow a much broader group of doctors to help tackle the opioid crisis.

DEA Extends Telemedicine Flexibilities for Prescription of Controlled Medications - 05/12/2023

To avoid lapses in patient care now that the COVID-19 public health emergency has ended, the Drug Enforcement Administration and the Substance Abuse and Mental Health Services Administration issued a temporary extension of telemedicine flexibilities for the prescribing of controlled medications originally adopted in March 2020.

TMA Asks AMA to Stay Out of Affordable Care Act Suit - 05/02/2023

Leaders of the Texas Medical Association on Tuesday publicly objected to the American Medical Association’s plans to get involved in a high-profile federal lawsuit — filed in Texas — challenging the constitutionality of the Affordable Care Act.

Medication-Assisted Treatment for Opioids, Alcohol, Tobacco: What You Should Know - 04/19/2023

Concern about opioids – especially the growing threat of overdose posed by illicit fentanyl – has created heightened awareness about treatment options for people with substance use disorders. One of the oldest and most effective is medication-assisted treatment.

UPDATE: Feds Declare Xylazine an Emerging National Threat in Opioid Crisis - 04/14/2023

Physicians’ ability to diagnose and treat opioid-related overdoses may be complicated by the discovery of the animal tranquilizer xylazine mixed in illicit fentanyl-laced drugs, the Texas Department of State Health Services warned in a recent health advisory.

Opioid Crisis: Illegally Manufactured Fentanyl Facts and Resources - 04/06/2023

Use these resources to get the facts and learn more about how illegally manufactured fentanyl is impacting public health.

Abbott Signals Support for Opioid Crisis Interventions: Federal Efforts Also Are Underway - 04/05/2023

Texas Gov. Greg Abbott in February listed the fentanyl crisis as one of seven “emergency” items this session, clearing a path toward passage of Texas Medical Association-backed legislation that aims to curb opioid-related deaths.

FDA Approves Naloxone Nasal Spray for Over-the-Counter Sale - 04/03/2023

The Food and Drug Administration has approved over-the-counter sales of the opioid-reversing medication Narcan nasal spray – a move Texas physicians have long championed.

DEA Permanently Lists Opioid Brorphine as a Schedule I Controlled Substance - 03/24/2023

The Drug Enforcement Administration recently listed the synthetic opioid brorphine as a Schedule I controlled substance, putting in in the same league as other potentially dangerous drugs that have no accepted medical use, like heroin and LSD.

TMA Analyzes FTC Proposed Ban on Noncompetes - 03/09/2023

The interplay between federal and state efforts to ban noncompete agreements remains unclear as Texas Medical Association experts analyze a proposed Federal Trade Commission (FTC) rule on the matter.